General Notices

• Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs
  (NOT-AI-21-037)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Pre-Application Webinar for Gabriella Miller Kids First Pediatric Research Program RFA-RM-21-011: Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
  (NOT-RM-21-020)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-144, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 BESH Required)"
  (NOT-AA-21-006)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-145, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
  (NOT-AA-21-007)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change to Award Information in PAR-20-108, "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
  (NOT-AI-21-038)
  National Institute of Allergy and Infectious Diseases
  

• Notice of NEI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
  (NOT-EY-21-008)
  National Eye Institute
  

• Notice of NICHD Participation in RFA-DA-21-020 "HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)"
  (NOT-HD-21-010)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in RFA-DA-21-021 "HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)"
  (NOT-HD-21-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in RFA-DA-21-022 "HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)"
  (NOT-HD-21-012)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in RFA-DA-21-023 "HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)"
  (NOT-HD-21-013)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Change to Participation for RFA-MH-20-620, "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)"
  (NOT-MH-21-200)
  National Institute of Mental Health
  National Cancer Institute
  National Eye Institute
  

• Notice of Expiration of RFA-RM-20-023 "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)"
  (NOT-RM-21-018)
  Office of Strategic Coordination (Common Fund)
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogrens Syndrome (UC2 Clinical Trial Optional)
  (NOT-AR-21-013)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed)
  (NOT-AR-21-014)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
  (NOT-MD-21-016)
  National Institute on Minority Health and Health Disparities
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional)
  (NOT-MH-21-185)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional)
  (NOT-MH-21-186)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional)
  (NOT-MH-21-187)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)
  (NOT-MH-21-188)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award
  (NOT-NS-21-030)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
  (NOT-NS-21-031)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  (NOT-NS-21-032)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

Requests for Proposal

• Request for Proposals (RFP) Notice: Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorders
  (NOT-DA-21-031)
  National Institute on Drug Abuse
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
  (NOT-AG-21-016)
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Using Data to Advance HIV Epidemic Knowledge and Program Planning
  (NOT-DA-21-007)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
  (NOT-EB-21-001)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements to STTR Regional Technology Transfer Accelerator Hubs to Provide Instruction in Business Fundamentals to Core Facility Directors
  (NOT-GM-21-017)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
  (NOT-GM-21-019)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Wellness and Resiliency in the Training Environment
  (NOT-GM-21-022)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Mentoring in the Research Training Environment
  (NOT-GM-21-023)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements to Enhance Program Evaluation Capacity
  (NOT-GM-21-024)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Enhance Undergraduate Biomedical Research Training
  (NOT-GM-21-025)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Promote Safe and Inclusive Biomedical Research Training Environments
  (NOT-GM-21-026)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments
  (NOT-GM-21-027)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences
  (NOT-GM-21-028)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core Facilities
  (NOT-GM-21-029)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS R01, R35, and R37 Awardees
  (NOT-GM-21-030)
  National Institute of General Medical Sciences
  

• RESCINDED - Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
  (NOT-MH-21-150)
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
  (NOT-TR-21-022)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed)
  (PAR-21-147)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 26, 2021; May 26, 2022; May 26, 2023
  
  

• NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed)
  (PAR-21-149)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 25, 2021, May 25, 2022, May 25, 2023
  
  

• The Midlife in the United States Study (U19 Clinical Trial Not Allowed)
  (PAR-21-156)
  National Institute on Aging
  Application Receipt Date(s): April 26, 2021; August 16, 2021; and February 1, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
  
  

• The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)
  (PAR-21-157)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)
  (RFA-DA-22-010)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 25, 2021, October 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
  (RFA-DE-22-001)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): July 26, 2021
  
  

• Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
  (RFA-HL-22-002)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): June 15, 2021
  
  

• Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-HL-22-003)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): June 15, 2021
  
  

• Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)
  (RFA-HL-22-007)
  National Heart, Lung, and Blood Institute
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): June 11, 2021
  
  

• Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)
  (RFA-HL-22-008)
  National Heart, Lung, and Blood Institute
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): June 11, 2021
  
  

• Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)
  (RFA-MH-21-120)
  National Institute of Mental Health
  Application Receipt Date(s): November 15, 2021
  
  

• NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-21-019)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 23, 2021